Zai Lab Limited
NASDAQ:ZLAB · NASDAQ Global Market
+$0.61 today
Vol 0.96M · Avg 0.87M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-49.51%
Period High
$40.51
Period Low
$16.30
Latest
$18.18
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Centessa Pharmaceuticals plc
NASDAQ:CNTA
$6.17B
Cidara Therapeutics, Inc.
CDTX
$5.61B
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.58B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.42B
Legend Biotech Corporation
NASDAQ:LEGN
$5.38B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.18B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.91B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.72B
Disc Medicine, Inc.
NASDAQ:IRON
$2.67B
Ascentage Pharma Group International
NASDAQ:AAPG
$408.11M
What is the latest ZLAB filing?
The latest filing shown is 8-K dated Jun 17, 2026.
How many recent filings does ZLAB have?
Intrinsic Alpha currently shows 20 recent filings for ZLAB.
Explore More
Continue the stock analysis
Jump to another research area for this company.